Spruce Street Capital »

Achieve Life Sciences shares owned by Spruce Street Capital

Quarter-by-quarter ownership of Achieve Life Sciences (ACHV) shares owned by Spruce Street Capital from 13F filings

Historical chart of Spruce Street Capital investment in Achieve Life Sciences

Tip: Access up to 7 years of quarterly data

All positions including Achieve Life Sciences held by Spruce Street Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achieve Life Sciences by Spruce Street Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.8M 737k 6.53

More positions owned by Spruce Street Capital

Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Relay Therapeutics (RLAY)
Lb Pharmaceuticals Com Shs (LBRX)
Relmada Therapeutics (RLMD)
Alto Neuroscience Com Shs (ANRO)
Dianthus Therapeutics (DNTH)
Alkermes SHS (ALKS)
Savara (SVRA)
Vaxcyte (PCVX)
Enliven Therapeutics (ELVN)
Enanta Pharmaceuticals (ENTA)
Perspective Therapeutics Com New (CATX)
Inflarx Nv (IFRX)
Surrozen Com New (SRZN)
Alumis (ALMS)

View all positions for Spruce Street Capital

Top funds holding Achieve Life Sciences

Franklin Resources
Vanguard Capital Management
Propel Bio Management
Marshall Wace
Simplify Asset Management
Millennium Management
Spruce Street Capital
LPL Financial
Nantahala Capital Management
Raymond James Financial
Geode Capital Management
Vanguard Fiduciary Trust
Two Sigma Investments
Vanguard Portfolio Management
Susquehanna International

View all funds holding Achieve Life Sciences